πŸ‡ΊπŸ‡Έ FDA
Patent

US 10543282

Targeted peptide conjugates

granted A61KA61K31/445A61K47/64

Quick answer

US patent 10543282 (Targeted peptide conjugates) held by Marker Gene Technologies, Inc expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Marker Gene Technologies, Inc
Grant date
Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/445, A61K47/64, A61K47/645